Literature DB >> 9649156

Aberrant crypt foci in patients with colorectal cancer.

L Roncucci1, S Modica, M Pedroni, M G Tamassia, M Ghidoni, L Losi, R Fante, C Di Gregorio, A Manenti, L Gafa, M Ponz de Leon.   

Abstract

Aberrant crypt foci (ACF) are clusters of abnormally large colonic crypts identified on the mucosal surface of the human colon. They are thought to be preneoplastic lesions. The aim of the present study was to compare density (number of ACF per square cm of mucosal surface), crypt multiplicity (number of crypts per ACF) and histology of ACF in colonic resections of colorectal cancer patients resident in two Italian provinces with a twofold difference in colorectal cancer incidence rates. Thirty-two and 26 colonic resections were collected after operation in Ragusa (Southern Italy) and Modena (Northern Italy), respectively, and fixed in 10% formalin. Mucosal layers were observed under a light microscope at 25x after staining with methylene blue. Density of ACF was significantly higher in Modena (median 0.101 ACF cm(-2)) than in Ragusa (0.049, P = 0.001), whereas there was no difference in crypt multiplicity. ACF were classified into three groups according to histological features: ACF with mild alterations (hypertrophic ACF, 73%), ACF with hyperplasia (hyperplastic ACF, 17%) and ACF with dysplasia (microadenomas, 10%). The proportions of ACF in the three groups were similar in the two provinces. Density of ACF was higher and crypt multiplicity lower proceeding from proximal to distal large bowel. Microadenomas were observed only in the colon, whereas hyperplastic ACF were more frequent in the rectum. In conclusion, density of ACF correlates with colorectal cancer rates in two Italian provinces, and shows a positive gradient from proximal to distal large bowel. Histology of ACF suggests that they may be precursors of both hyperplastic and adenomatous polyps. These data provide further evidence of the role of ACF in human colorectal carcinogenesis.

Entities:  

Mesh:

Year:  1998        PMID: 9649156      PMCID: PMC2150380          DOI: 10.1038/bjc.1998.389

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry.

Authors:  M Kouri; A Laasonen; J P Mecklin; H Järvinen; K Franssila; S Pyrhönen
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

2.  Histology of aberrant crypt foci in the human colon.

Authors:  C Di Gregorio; L Losi; R Fante; S Modica; M Ghidoni; M Pedroni; M G Tamassia; L Gafà; M Ponz de Leon; L Roncucci
Journal:  Histopathology       Date:  1997-04       Impact factor: 5.087

3.  Background mucosal changes in colorectal carcinomas.

Authors:  Y S Lee
Journal:  Cancer       Date:  1988-04-15       Impact factor: 6.860

4.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

5.  Identification and quantification of aberrant crypt foci and microadenomas in the human colon.

Authors:  L Roncucci; D Stamp; A Medline; J B Cullen; W R Bruce
Journal:  Hum Pathol       Date:  1991-03       Impact factor: 3.466

6.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

7.  Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings.

Authors:  R P Bird
Journal:  Cancer Lett       Date:  1987-10-30       Impact factor: 8.679

8.  Aberrant crypts: potential preneoplastic lesions in the murine colon.

Authors:  E A McLellan; R P Bird
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

9.  Expression of carcinoembryonic antigen, T-antigen, and oncogene products as markers of neoplastic and preneoplastic colonic mucosa.

Authors:  K J McKenzie; D M Purnell; A M Shamsuddin
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

10.  Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

Authors:  T P Pretlow; B J Barrow; W S Ashton; M A O'Riordan; T G Pretlow; J A Jurcisek; T A Stellato
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  12 in total

1.  Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.

Authors:  M Anti; A Armuzzi; S Morini; E Iascone; G Pignataro; C Coco; R Lorenzetti; M Paolucci; M Covino; A Gasbarrini; F Vecchio; G Gasbarrini
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 2.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

Review 3.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

4.  CpG island methylation in aberrant crypt foci of the colorectum.

Authors:  Annie On-On Chan; Russell R Broaddus; Patrick S Houlihan; Jean-Pierre J Issa; Stanley R Hamilton; Asif Rashid
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 5.  Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies.

Authors:  Richard G Stevens; Helen Swede; Daniel W Rosenberg
Journal:  Cancer Lett       Date:  2006-12-19       Impact factor: 8.679

6.  APC and K-ras gene mutation in aberrant crypt foci of human colon.

Authors:  P Yuan; M H Sun; J S Zhang; X Z Zhu; D R Shi
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

7.  Identification of key candidate genes and pathways associated with colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.

Authors:  Setareh Fayazfar; Afsaneh Arefi Oskouie; Akram Safaei; Hakimeh Zali; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

Review 8.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.

Authors:  Pedro Figueiredo; Maria Donato; Marta Urbano; Helena Goulão; Hermano Gouveia; Carlos Sofia; Maximino Leitão; Diniz Freitas
Journal:  Int J Colorectal Dis       Date:  2008-09-04       Impact factor: 2.571

10.  A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat.

Authors:  B S Han; C B Park; N Takasuka; A Naito; K Sekine; E Nomura; H Taniguchi; T Tsuno; H Tsuda
Journal:  Jpn J Cancer Res       Date:  2001-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.